These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9832367)

  • 21. Potassium is not a good solute to estimate residual volume in CAPD.
    Abensur H; Marmanillo C; Romao JE; Kakehashi E; Marcondes M; Sabbaga E
    Adv Perit Dial; 1995; 11():45-7. PubMed ID: 8534735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients].
    Dai HL; Lin AW; Qian JQ; Fang W; Ni ZH; Cao LO; Lin XH; Wu QW
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2843-7. PubMed ID: 21162796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dialysis with icodextrin interferes with measurement of serum alpha-amylase activity.
    Schoenicke G; Grabensee B; Plum J
    Nephrol Dial Transplant; 2002 Nov; 17(11):1988-92. PubMed ID: 12401858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Icodextrin: What arguments for and against its use as an osmotic agent in peritoneal dialysis].
    Savenkoff B; Flechon-Meibody F; Goffin É
    Nephrol Ther; 2018 Jun; 14(4):201-206. PubMed ID: 29291942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of different volume markers in peritoneal dialysis.
    De Paepe M; Belpaire F; Schelstraete K; Lameire N
    J Lab Clin Med; 1988 Apr; 111(4):421-9. PubMed ID: 2450938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.
    Konings CJ; Kooman JP; Schonck M; Gladziwa U; Wirtz J; van den Wall Bake AW; Gerlag PG; Hoorntje SJ; Wolters J; van der Sande FM; Leunissen KM
    Kidney Int; 2003 Apr; 63(4):1556-63. PubMed ID: 12631373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of icodextrin to provide adequate ultrafiltration in continuous ambulatory peritoneal dialysis patients.
    Thodis E; Passadakis P; Panagoutsos S; Marinopoulos D; Vargemezis V
    Adv Perit Dial; 1999; 15():171-4. PubMed ID: 10682096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic consequences of peritoneal dialysis.
    Burkart J
    Semin Dial; 2004; 17(6):498-504. PubMed ID: 15660581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal transport characteristics with glucose polymer-based dialysis fluid in children.
    Rusthoven E; Krediet RT; Willems HL; Monnens LA; Schröder CH
    J Am Soc Nephrol; 2004 Nov; 15(11):2940-7. PubMed ID: 15504948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quantitative description of solute and fluid transport during peritoneal dialysis.
    Heimbürger O; Waniewski J; Werynski A; Lindholm B
    Kidney Int; 1992 May; 41(5):1320-32. PubMed ID: 1614047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinetics of water transperitoneal transport during long-term peritoneal dialysis performed using icodextrin dialysis fluid.
    Olszowska A; Zelichowski G; Waniewski J; Stachowska-Pietka J; Weryński A; Wańkowicz Z
    Pol Arch Med Wewn; 2009 May; 119(5):305-10. PubMed ID: 19579812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
    Amici G; Orrasch M; Da Rin G; Bocci C
    Adv Perit Dial; 2001; 17():80-3. PubMed ID: 11510303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of icodextrin on insulin resistance and adipocytokine profiles in patients on peritoneal dialysis.
    Takeguchi F; Nakayama M; Nakao T
    Ther Apher Dial; 2008 Jun; 12(3):243-9. PubMed ID: 18503703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gel permeation chromatography of dextrans in parenteral solutions: calibration procedure development and method validation.
    Karmarkar S; Garber R; Kluza J; Koberda M
    J Pharm Biomed Anal; 2006 Jun; 41(4):1260-7. PubMed ID: 16650708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients.
    Gürsu EM; Ozdemir A; Yalinbas B; Gürsu RU; Canbakan M; Güven B; Atasoyu EM; Keskin AT; Elçi A; Baru Y
    Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long daytime exchange in children on continuous cycling peritoneal dialysis: preservation of drained volume because of icodextrin use.
    Michallat AC; Dheu C; Loichot C; Danner S; Fischbach M
    Adv Perit Dial; 2005; 21():195-9. PubMed ID: 16686317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions.
    Parikova A; Zweers MM; Struijk DG; Krediet RT
    Adv Perit Dial; 2003; 19():186-90. PubMed ID: 14763059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial.
    Davies SJ; Woodrow G; Donovan K; Plum J; Williams P; Johansson AC; Bosselmann HP; Heimbürger O; Simonsen O; Davenport A; Tranaeus A; Divino Filho JC
    J Am Soc Nephrol; 2003 Sep; 14(9):2338-44. PubMed ID: 12937311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin.
    Hosie K; Gilbert JA; Kerr D; Brown CB; Peers EM
    Drug Deliv; 2001; 8(1):9-12. PubMed ID: 11280443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.